Neuroblastoma Clinical Trials: Looking at Patterns About How Patients Feel About Participating in Clinical Trials
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Rate of patients who remain in neuroblastoma clinical trial to trial completion
研究概览
简要总结
Historically, participation in clinical research is highly skewed towards particular demographic groups of people.
This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma.
The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed diagnosis of neuroblastoma
- •Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- •Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
排除标准
- •Women of childbearing potential without a negative pregnancy test; or women who are lactating.
- •Any serious and/or unstable pre-existing medical disorders
- •Enrolled in another research study
结局指标
主要结局
Rate of patients who remain in neuroblastoma clinical trial to trial completion
时间窗: 12 months
Number of patients who decide to enroll in a neuroblastoma clinical trial
时间窗: 3 months
次要结局
未报告次要终点